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Purpose/Objective: The determination of beam width for 
selected energy and focus combinations is frequently 
performed at the Heidelberg Ion-Beam Therapy Center (HIT). 
For beam width adjustment a scintillating screen detector 
(SD, in-house production) is used and radiographic film is 
employed for the subsequent quality assurance. As the width 
measurement results of these detectors show deviations, an 
iterative beam adjustment process is used. To improve and 
speed up this process and to replace the irradiation- and 
evaluation-time-intensive film measurements, a comparison 
of 5 different detectors is currently performed. 
Materials and Methods: Vertically scanned carbon ion line 
fields with a beam width of 6-10mm were used to compare 
lateral beam width results from radiographic Xomat V film 
(Kodak), a SD, a flatpanel detector (FPD, XRD 0822 without 
scintillator, PerkinElmer) and a multiwire chamber (MW, 
MWPC Type I, Siemens) against those from a linear array of 
12 pinpoint ionization chambers (IC, TM31015, PTW) as the 
gold standard in absolute dosimetry. For the first 3 detectors 
background corrected .tiff images containing the 
accumulated measurement of the whole scanned irradiation 
field were used as the result. As the MW integrates over 
time-increments of 400 µs, the beam width was calculated 
for each of these time-increments and the final result 
subsequently averaged over all single measurements. For the 
IC results, serving as the reference, the array was shifted in 
2mm steps perpendicular to the scanned field and the 
irradiation repeated for each array position. For all 
detectors, the lateral beam width was obtained as the FWHM 
value and complementary calculated from a single Gaussian 
fit. 
Results: The comparison of the beam width measured with 
different detectors compared to IC measurements resulted in 
the maximum deviations presented in Tab. 1. 
 
 
 
Tab. 1: Comparison of the beam width measured with 
different detectors compared to measurements with a linear 
IC array. 
 
Conclusions: The beam width results from 4 detectors 
compared to IC measurements show good agreement below 
0.5mm for FWHM values obtained from SD and FPD 
measurements. With film and MW, larger deviations from the 
IC results were observed and need to be further investigated. 
A comparison of the results also shows that SD and FD 
measure a beam width larger than the IC, while the beam 
widths obtained with film and MW are smaller. Currently, 
results from line and single spot fields are compared and the 
beam width evaluation is further optimized.  
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Purpose/Objective: The purpose of this study was to 
independently verify the manufacturer’s stated CAX dose-
rate from a Ru-106 eye plaque. Due to the small dimensions 
and curvature of Ru-106 plaques, the determination of the 
dosimetric characteristics represents a technical challenge 
with relatively large uncertainties. This makes it difficult for 
an institution to implement a robust system to verify a 
plaques dose-rate before it is used clinically. Previous studies 
have investigated the PTW Diamond detector and different 
versions of Radiochromic film for beta plaque dosimetry. Two 
relatively new additions to the market, the PTW 
Microdiamond detector and EBT3 film have yet to be 
evaluated.  
Materials and Methods: EBT3 films were inserted between 
1mm sheets of Plastic Water® cut to different sized 
concentric circles in order to fit within the plaque’s concave 
face for 90 minutes. Each film yielded the dose-rate at 
regular intervals perpendicular to the plaque surface. The 
PTW Microdiamond detector was mounted vertically in a 
water tank, suspended by Vernier callipers which were 
modified to allow the precise vertical movement of the 
detector along the plaques CAX. Each distance measurement 
was undertaken for 120 seconds to obtain a reasonable signal 
up to 1cm from the plaque surface. The results were 
compared to the PTW Diamond detector results obtained 
using the same configuration. 
Results: The reference dose rate measured independently 
using EBT3 film in this work was found to agree with the 
manufacturer’s calibration certificate dose rate to within 
1.5% +/- 16%. The PTW Diamond and Microdiamond measured 
reference dose rates agreed the calibration certificate dose 
rate within 8.3% +/- 14.4% and 48.8% +/- 14.6% respectively. 
The uncertainties were comparable to the manufacturer’s 
calibration uncertainty of +/-20%. 
Conclusions: This study found that EBT3 film and the PTW 
Diamond detector are effective tools in validating the 
manufacturers stated dose rates. The results of both 
detectors lie within the manufacturer’s calibration 
certificate uncertainty of +/-20%. However, the new PTW 
Microdiamond yielded a consistently higher reference dose 
rate (>48%) when compared to the EBT3 film and PTW 
Diamond detector. The authors propose the difference is due 
to the energy dependence attributed to the difference in 
construction materials, elucidated using a Micro-CT system, 
between the two detectors. In addition, a PTW SourceCheck 
air ionisation chamber was evaluated as a consistency check 
tool to verify the Ru-106 plaque dose rate on a routine basis. 
Placing a Ru-106 plaque in the centre of the PTW 
